medigraphic.com
ISSN 1561-302X (Print)

2023, Number 1

<< Back Next >>

Rev cubana med 2023; 62 (1)

Risk factors for mortality in patients with exacerbated chronic obstructive pulmonary disease

Rodríguez CJP, Conde FBD, Orellana MGA, Valdés RMF, Lorenzo RJM, Valdés RAM

Language: Spanish
References: 25
Page: 1-11
PDF size: 426.76 Kb.


ABSTRACT

Introduction: Chronic obstructive pulmonary disease is a health problem; It is the third cause of death in the world, the exacerbation of this disease is responsible for the death of a high percentage of patients.
Objective: To identify risk factors for mortality in hospitalized patients with exacerbated chronic obstructive pulmonary disease.
Methods: A cross-sectional, analytical investigation was carried out, based on the epidemiological design of correlational studies, at the “Camilo Cienfuegos” Provincial General Hospital of Sancti Spíritus, for two years. 335 patients were included. Sociodemographic and clinical variables were studied. To identify risk factors, a binary logistic regression model was developed using the Wald forward method. Mortality during hospitalization for exacerbated COPD was considered the dependent variable.
Results: In the logistic regression model, the global percentage index that showed the relationship between what was predicted with respect to what was observed was 94, 6 %. The predictors used explained 86, 3 % of the variability of the dependent variable. Statistical analysis allowed us to identify the following risk factors for mortality: acute respiratory failure, diagnosis of pneumonia, pulmonary thromboembolism, age over 60 years, and smoking addiction.
Conclusions: The identification of five mortality risk factors in patients hospitalized for exacerbated COPD, with the use of a predictive model to calculate the probability of death; contributes to the improvement of individualized medical care, in order to minimize the occurrence of fatal events in these patients.


REFERENCES

  1. Halpin DMG, Celli BR, Criner GJ. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis 2019 [acceso:28/06/2022];23(11):1131-41. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31718748/1.

  2. Organización Mundial de la Salud. Las 10 principales cusas de defunción. Media centre. Génova: OMS; 9 de diciembre de 2020. [acceso: 12/01/2022].. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/the-top-10-causes-of-death2.

  3. MINSAP. Dirección de registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2020. La Habana: 2021. [acceso: 12/04/2022]. Disponible en: https://files.sld.cu/bvscuba/files/2020/05/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2019-ed-20203.

  4. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. Report 2022 [acceso:20/04/2022]. Disponible en: https://goldcopd.org/2022-gold-reports-2/4.

  5. Wang R, Xu J, Wang Y. Encuesta poblacional sobre la prevalencia y los factores de riesgo de la enfermedad pulmonar obstructiva crónica en la provincia de Shanxi (China). Revista Clínica Española. 2022;222(4):218-28. DOI: https://doi.org/10.1016/j.rce.2021.04.0105.

  6. Despaigne Salazar R, Benítez Sánchez E, Guzmán Pérez N, Oliva Corujo L, Acosta Arafet N. Factores pronósticos de letalidad en pacientes con enfermedad pulmonar obstructiva crónica en cuidados intensivos. Rev Cuban de Med Milit. 2018 [acceso:19/05/2022];47(3):1-14. Disponible en: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/1526.

  7. Spannella F, Giulietti F, Cocci G, Landi L, Lombardi FE, Borioni E, et al. Acute exacerbation of chronic obstructive pulmonary disease in oldest adults: predictors of in-hospital mortality and need for post-acute care. Journal of the American Medical Directors Association. 2019;20(7):893-8. DOI: https://doi.org/10.1016/j.jamda.2019.01.1257.

  8. Puruncajas Alvear JL. Factores asociados a reingresos en pacientes con enfermedad pulmonar obstructiva crónica en el Servicio de Neumología en el Hospital Pablo Arturo Suárez desde enero de 2016 hasta diciembre 2018. 2021 [acceso:15/08/2022]. Disponible en: http://repositorio.puce.edu.ec:80/handle/22000/186468.

  9. Lajas AC, Puente Maestu L, De J, Díez M. Relevancia de la comorbilidad en la EPOC. Rev Patolog Resp. 2019 [acceso:15/05/2022];22(3):81-3. Disponible en: https://www.revistadepatologiarespiratoria.org/descargas/PR_22-3_81-83.pdf9.

  10. Pérez IR, Álvarez AM, Rodríguez ZN, García LR, Pérez NG, Castillo SP. Factores pronósticos de mortalidad de la enfermedad pulmonar obstructiva crónica exacerbada en emergencias. Acta Colombiana de Cuidado Intensivo. 2021;21(1):22-32. DOI: https://doi.org/10.1016/j.acci.2020.04.00610.

  11. Pasquale CB, Vietri J, Choate R, McDaniel A, Sato R, Ford KD, et al. Patient-reported consequences of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation. 2019 [acceso: 17/05/2022];6(2):132. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596434/11.

  12. John Reilly. Enfermedades del aparato respiratorio. En: Goldman L, Schafer AI, editores. Goldman-Cecil. Tratado de Medicina Interna. Vol 2. 26.aed. España: Elsevier; 2021 [acceso:11/07/2022];537-46. Disponible en: Disponible en: https://www.elsevier.com/books/goldman-cecil.-tratado-de-medicina-interna/978-84-9113-765-8 12.

  13. López-Jiménez F, Cortés-Bergoderi M. Obesidad y corazón. Rev Español cardiol2011;64(2):140-9. DOI: https://doi.org/10.1016/j.recesp.2010.10.01013.

  14. Cantín M. Asociación Médica Mundial. Declaración de Helsinki: Principios éticos para las investigaciones médicas en seres humanos. Revisando su última versión. Int J Med Surg Sci 2014 [acceso: 15/08/2022];1(4):339-46. Disponible en: http://www.ijmss.org/wpcontent/uploads/2015/05/art_8_14.pdf14.

  15. Rodríguez-Pérez I, Sagaró-del-Campo NM, Zamora-Matamoros L, Martínez-Álvarez A. Factores pronósticos en la enfermedad pulmonar obstructiva crónica exacerbada. Revista Electrónica Dr Zoilo E Marinello Vidaurreta.. 2021 [acceso:21/05/2022];46(2):2643. Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/264315.

  16. Poulsen SH, Noer I, Møller J, Knudsen T, Frandsen JL. Clinical outcome of patients with suspected pulmonary embolism. A follow-up study of 588 consecutive patients. Journ of internal medic. 2001 [acceso: 22/05/2022];250(2):137-43. Disponible en: https://pubmed.ncbi.nlm.nih.gov/11489063/16.

  17. Chen W-J, Lin C-C, Lin C-Y, Chang Y-J, Sung F-C, Kao C-H, et al. Pulmonary embolism in chronic obstructive pulmonary disease: a population-based cohort study. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2014;11(4):438-43. DOI: https://doi.org/10.3109/15412555.2013.81392717.

  18. Wang J, Ding Y. Prevalence and risk factors of pulmonary embolism in acute exacerbation of chronic obstructive pulmonary disease and its impact on outcomes: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021 [acceso: 23/05/2022];25(6):2604-16. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33829447/18.

  19. Harenberg J, Verhamme P. The Dangerous Liaisons between chronic obstructive pulmonary disease and venous thromboembolism. Thrombosis and Haemostasis. 2020;120(03):363-5. DOI : https://doi.org/10.1055/s-0039-170101219.

  20. Børvik T, Brækkan SK, Evensen LH, Brodin EE, Morelli VM, Melbye H, et al. Chronic Obstructive Pulmonary Disease and Risk of Mortality in Patients with Venous Thromboembolism-The Tromsø Study. Thrombosis and Haemostasis. 2020;120(03):477-83. DOI: https://doi.org/10.1055/s-0039-340074420. .

  21. Pourmand A, Robinson H, Mazer-Amirshahi M, Pines JM. Pulmonary embolism among patients with acute exacerbation of chronic obstructive pulmonary disease: implications for emergency medicine. The Journal of Emergency Medicine. 2018;55(3):339-46. DOI: https://doi.org/10.1016/j.jemermed.2018.05.02621.

  22. Agarwal R, Gupta R, Aggarwal AN, Gupta D. Noninvasive positive pressure ventilation in acute respiratory failure due to COPD vs other causes: effectiveness and predictors of failure in a respiratory ICU in North India. International Journal of Chronic Obstructive Pulmonary Disease. 2008 [acceso:15/06/2022];3(4):737. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19281088/22.

  23. Garcia IS, Clarà PC. Causes of death and prediction of mortality in COPD. Archivos de Bronconeumología. 2010;46(7):343-6. DOI: https://doi.org/10.1016/j.arbres.2010.04.00123.

  24. Puhan MA, Garcia-Aymerich J, Frey M, ter Riet G, Antó JM, Agustí AG, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. The Lancet. 2009 [acceso 17/06/2022];374(9691):704-11. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19716962/24.

  25. Muñoz JCF, Moreno DB, Guerra AF, Aguilera JCG, Almarales YR. Factores pronósticos de muerte en la Enfermedad Pulmonar Obstructiva Crónica. Revista Cubana de Medicina Intensiva y Emergencias. 2012 [acceso: 17/06/2022];11(1):2358-73.




2020     |     www.medigraphic.com